Royalty Pharma plc
RPRXBiotechnology
$67.18+1.90%As of Oct 30vs prior close
- Market cap
- $38.8B
- P/E (TTM)
- 35.9×
- P/E (FY1)
- 12.6×
- From 52W high
- 0.00%
- EPS (LTM)
- $1.87
- Revenue (LTM)
- $2.5B
- Net margin
- 32.02%
- Dividend yield
- 1.38%
Nomior Score
80
Steady ProfileTop 2% of the scored universe
Growth58
Quality63
Value65
Momentum98
Resilience58
Growth
+4.10%revenue a year over 7 fiscal years
YE18 $1.8BLTM $2.5B
Connections
Revenue to profitQ2 YE26
3% of revenue became net profit, down 3 pts on a year.
Who owns it
1tracked portfolio